Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CNMD CONMED	$54.64 +0.7%	$52.15	$46.00 ▼ $78.19	$1.68B	1.17	556,630 shs	254,877 shs
ENOV Enovis	$31.20 +0.7%	$30.04	$25.47 ▼ $49.83	$1.77B	1.7	1.18 million shs	1.19 million shs
EYE National Vision	$24.55 +2.6%	$24.07	$9.56 ▼ $25.67	$1.90B	1.27	2.25 million shs	1.97 million shs
SMLR Semler Scientific	$30.79 +2.6%	$37.52	$21.77 ▼ $81.56	$444.44M	1.34	592,464 shs	373,129 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CNMD CONMED	-2.69%	+1.87%	+6.72%	-6.12%	-24.47%
ENOV Enovis	-1.36%	+5.00%	+12.52%	-7.35%	-32.70%
EYE National Vision	-3.62%	+0.25%	-4.36%	+25.88%	+127.69%
SMLR Semler Scientific	-4.49%	-11.08%	-21.17%	-30.81%	+2.32%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CNMD CONMED	3.9278 of 5 stars	1.1	2.0	2.5	4.3	3.0	0.0	3.1
ENOV Enovis	4.5453 of 5 stars	4.5	3.0	0.0	0.0	4.2	3.3	1.9
EYE National Vision	2.7544 of 5 stars	2.3	2.0	0.0	3.3	3.5	0.0	0.0
SMLR Semler Scientific	3.4313 of 5 stars	3.6	4.0	0.0	0.0	2.6	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CNMD CONMED	2.20	Hold	$59.80	9.44% Upside
ENOV Enovis	3.00	Buy	$51.00	63.49% Upside
EYE National Vision	2.60	Moderate Buy	$24.73	0.72% Upside
SMLR Semler Scientific	3.25	Buy	$81.75	165.51% Upside

Current Analyst Ratings Breakdown

Latest SMLR, EYE, ENOV, and CNMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	ENOV Enovis	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$70.00 ➝ $58.00
8/8/2025	ENOV Enovis	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$65.00 ➝ $57.00
8/8/2025	ENOV Enovis	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$48.00 ➝ $41.00
8/7/2025	ENOV Enovis	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$57.00 ➝ $49.00
8/7/2025	EYE National Vision	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$17.00 ➝ $22.00
8/7/2025	EYE National Vision	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$24.00 ➝ $27.00
8/7/2025	EYE National Vision	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$30.00 ➝ $28.00
8/6/2025	SMLR Semler Scientific	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$61.00 ➝ $60.00
7/31/2025	CNMD CONMED	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$80.00 ➝ $68.00
7/30/2025	EYE National Vision	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$36.00
7/28/2025	SMLR Semler Scientific	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$61.00

(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CNMD CONMED	$1.31B	1.29	$6.76 per share	8.08	$32.40 per share	1.69
ENOV Enovis	$2.11B	0.85	$19.38 per share	1.61	$45.15 per share	0.69
EYE National Vision	$1.82B	1.07	$1.68 per share	14.63	$10.74 per share	2.29
SMLR Semler Scientific	$56.29M	8.10	$4.59 per share	6.71	$25.90 per share	1.19

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CNMD CONMED	$132.42M	$3.53	15.48	10.78	1.85	8.31%	14.43%	6.05%	10/29/2025 (Estimated)
ENOV Enovis	-$825.49M	-$14.25	N/A	9.78	N/A	-37.80%	6.78%	3.73%	11/5/2025 (Estimated)
EYE National Vision	-$28.50M	-$0.18	N/A	90.93	2.83	-0.75%	3.56%	1.49%	11/5/2025 (Estimated)
SMLR Semler Scientific	$40.90M	$2.43	12.67	∞	N/A	86.20%	43.84%	32.88%	11/3/2025 (Estimated)

Latest SMLR, EYE, ENOV, and CNMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	ENOV Enovis	$0.74	$0.79	+$0.05	-$0.64	$555.80 million	$564.50 million
8/6/2025	Q2 2025	EYE National Vision	$0.12	$0.18	+$0.06	$0.11	$469.21 million	$486.42 million
8/4/2025	Q2 2025	SMLR Semler Scientific	-$0.27	$5.04	+$5.31	$5.04	$8.10 million	$8.22 million
7/30/2025	Q2 2025	CNMD CONMED	$1.13	$1.15	+$0.02	$0.69	$338.42 million	$342.35 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CNMD CONMED	$0.80	1.46%	N/A	22.66%	N/A
ENOV Enovis	N/A	N/A	N/A	N/A	N/A
EYE National Vision	N/A	N/A	N/A	N/A	N/A
SMLR Semler Scientific	N/A	N/A	N/A	N/A	N/A

Latest SMLR, EYE, ENOV, and CNMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/8/2025	CNMD CONMED	quarterly	$0.20	1.5%	9/15/2025	9/15/2025	10/3/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CNMD CONMED	0.88	2.23	1.00
ENOV Enovis	0.53	2.25	1.15
EYE National Vision	0.30	0.52	0.31
SMLR Semler Scientific	0.25	0.60	0.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CNMD CONMED	N/A
ENOV Enovis	98.45%
EYE National Vision	N/A
SMLR Semler Scientific	49.37%

Insider Ownership

Company	Insider Ownership
CNMD CONMED	3.10%
ENOV Enovis	2.70%
EYE National Vision	2.70%
SMLR Semler Scientific	16.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CNMD CONMED	3,900	30.95 million	30.00 million	Optionable
ENOV Enovis	7,367	57.16 million	55.62 million	Optionable
EYE National Vision	13,411	79.20 million	77.06 million	Optionable
SMLR Semler Scientific	120	14.81 million	12.38 million	Not Optionable

SMLR, EYE, ENOV, and CNMD Headlines

Recent News About These Companies

Kovitz Investment Group Partners LLC Has $378,000 Stock Holdings in Semler Scientific Inc. $SMLR

August 24 at 3:51 AM | marketbeat.com

LPL Financial LLC Decreases Position in Semler Scientific Inc. (NASDAQ:SMLR)

August 18, 2025 | marketbeat.com

Maxim Group Maintains a Buy Rating on Semler Scientific (SMLR), Sets a $95 PT

August 14, 2025 | msn.com

Benchmark Co. Sticks to Their Buy Rating for Semler Scientific (SMLR)

August 12, 2025 | theglobeandmail.com

Semler Scientific’s Earnings Call: Bitcoin Gains Amid Challenges

August 12, 2025 | theglobeandmail.com

Cantor Fitzgerald Lowers Semler Scientific (NASDAQ:SMLR) Price Target to $60.00

August 7, 2025 | marketbeat.com

Forecasting The Future: 4 Analyst Projections For Semler Scientific

August 6, 2025 | benzinga.com

Semler Scientific, Inc. (NASDAQ:SMLR) Q2 2025 Earnings Call Transcript

August 6, 2025 | insidermonkey.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

August 6, 2025 | globenewswire.com

Semler Scientific Stock SMLR Rises After Bitcoin Gains Fuel Q2 Results

August 6, 2025 | bitcoinmagazine.com

Bitcoin Treasury Firm Semler Scientific Still Has 3X Upside: Benchmark

August 6, 2025 | finance.yahoo.com

Semler Scientific (NASDAQ:SMLR) Posts Quarterly Earnings Results, Beats Expectations By $5.31 EPS

August 5, 2025 | marketbeat.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

August 5, 2025 | prnewswire.com

Semler Scientific, Inc. (SMLR) Q2 2025 Earnings Call Transcript

August 4, 2025 | seekingalpha.com

Semler (SMLR) Q2 EPS Surges on Bitcoin

August 4, 2025 | fool.com

Semler Scientific® Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025

August 4, 2025 | prnewswire.com

Semler Scientific's Earnings Outlook

August 2, 2025 | benzinga.com

SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

August 1, 2025 | globenewswire.com

Pacer Advisors Inc. Takes Position in Semler Scientific Inc. (NASDAQ:SMLR)

July 31, 2025 | marketbeat.com

Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR

July 30, 2025 | prnewswire.com

SEMLER INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Semler Scientific Inc. on Behalf of Semler Stockholders and Encourages Investors to Contact the Firm

July 29, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SMLR, EYE, ENOV, and CNMD Company Descriptions

CONMED NYSE:CNMD

$54.64 +0.36 (+0.67%)

Closing price 03:59 PM Eastern

Extended Trading

$54.78 +0.14 (+0.26%)

As of 06:30 PM Eastern

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Enovis NYSE:ENOV

$31.20 +0.21 (+0.66%)

Closing price 03:59 PM Eastern

Extended Trading

$31.28 +0.08 (+0.26%)

As of 06:30 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

National Vision NASDAQ:EYE

$24.55 +0.62 (+2.59%)

Closing price 04:00 PM Eastern

Extended Trading

$24.55 0.00 (0.00%)

As of 07:26 PM Eastern

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Semler Scientific NASDAQ:SMLR

$30.79 +0.77 (+2.56%)

Closing price 04:00 PM Eastern

Extended Trading

$31.04 +0.25 (+0.80%)

As of 07:58 PM Eastern

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time